← Back to all trials
Not Yet Recruiting
NCT07772375
225 IU Versus 300 IU Starting FSH Dose in PPOS for Good-Prognosis Women
Conditions: Infertility (IVF Patients), Infertility Assisted Reproductive Technology
Sex: Female
Ages: 18 Years – 34 Years
Healthy volunteers: No
Phase: NA
Enrollment: 380
Sponsor: Vietnam Military Medical University
Location: An Sinh Hospital Ho Chi Minh City Ho Chi Minh City
Summary
This randomized controlled trial will compare two starting doses of follicle-stimulating hormone (FSH), 225 IU and 300 IU, during progestin-primed ovarian stimulation (PPOS) in women undergoing in vitro fertilization (IVF) who have a good reproductive prognosis. Participants will be randomly assigned to receive either 225 IU or 300 IU of FSH at the start of ovarian stimulation. The study will evaluate whether the starting FSH dose affects oocyte and embryo outcomes, with blastocyst formation as the primary outcome. Other outcomes will include oocyte morphology, fertilization, embryo development, and embryo quality. The findings may help determine an appropriate starting FSH dose for women with a good prognosis undergoing IVF using the PPOS protocol.
Eligibility Criteria
Inclusion Criteria:
* Female patient or oocyte donor aged \
Source: ClinicalTrials.gov (NCT07772375). StuddyBuddy aggregates publicly available trial information.
